{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:52:47Z","timestamp":1791003167681,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00586-026-09767-7","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:19:38Z","timestamp":1770351578000},"page":"6082-6088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton pump inhibitor use is associated with increased complications compared to H2-receptor antagonists following multi-level lumbar fusion: a retrospective cohort study"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6804-5972","authenticated-orcid":false,"given":"Uttsav","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7795-7873","authenticated-orcid":false,"given":"Rafael","family":"B. Madera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0833-8281","authenticated-orcid":false,"given":"Sean","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-7382","authenticated-orcid":false,"given":"Brian","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"1","key":"9767_CR1","first-page":"1","volume":"31","author":"PC Reid","year":"2019","unstructured":"Reid PC, Morr S, Kaiser MG (2019) State of the union: a review of lumbar fusion indications and techniques for degenerative spine disease: JNSPG 75th anniversary invited review Article. J Neurosurgery: Spine 31(1):1\u201314","journal-title":"J Neurosurgery: Spine"},{"issue":"1","key":"9767_CR2","first-page":"42","volume":"21","author":"JC Eck","year":"2014","unstructured":"Eck JC et al (2014) Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 7: lumbar fusion for intractable low-back pain without stenosis or spondylolisthesis. J Neurosurgery: Spine 21(1):42\u201347","journal-title":"J Neurosurgery: Spine"},{"issue":"3","key":"9767_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.amjmed.2021.09.010","volume":"135","author":"K Clarke","year":"2022","unstructured":"Clarke K et al (2022) Indications for the use of proton pump inhibitors for stress ulcer prophylaxis and peptic ulcer bleeding in hospitalized patients. Am J Med 135(3):313\u2013317","journal-title":"Am J Med"},{"issue":"26","key":"9767_CR4","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMra1605507","volume":"378","author":"D Cook","year":"2018","unstructured":"Cook D, Guyatt G (2018) Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med 378(26):2506\u20132516","journal-title":"N Engl J Med"},{"issue":"5","key":"9767_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/intqhc\/mzaa041","volume":"32","author":"PA Nguyen","year":"2020","unstructured":"Nguyen PA et al (2020) Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia. Int J Qual Health Care 32(5):292\u2013299","journal-title":"Int J Qual Health Care"},{"key":"9767_CR6","doi-asserted-by":"crossref","unstructured":"Ali AA, Bhongade BA, Alkaabi FM (2025) The Effect of Proton Pump Inhibitors on Bone Mineral Density at Specific Anatomical Sites: A Systematic Review and Meta-Analysis. Biomed Res Int, 2025: p. 1269905","DOI":"10.1155\/bmri\/1269905"},{"issue":"18","key":"9767_CR7","doi-asserted-by":"publisher","first-page":"10733","DOI":"10.3390\/ijms231810733","volume":"23","author":"E Lespessailles","year":"2022","unstructured":"Lespessailles E, Toumi H (2022) Proton pump inhibitors and bone health: an update narrative review. Int J Mol Sci 23(18):10733","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9767_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/03602532.2019.1610767","volume":"51","author":"A Mester","year":"2019","unstructured":"Mester A et al (2019) The impact of proton pump inhibitors on bone regeneration and implant osseointegration. Drug Metab Rev 51(3):330\u2013339","journal-title":"Drug Metab Rev"},{"key":"9767_CR9","doi-asserted-by":"publisher","first-page":"725359","DOI":"10.3389\/fmed.2021.725359","volume":"8","author":"S Gao","year":"2021","unstructured":"Gao S et al (2021) Prolonged use of proton pump inhibitors, but not histamine-2 receptor antagonists, is associated with lower bone mineral density in males aged over 70. Front Med 8:725359","journal-title":"Front Med"},{"key":"9767_CR10","doi-asserted-by":"crossref","unstructured":"Chang Y et al (2025) The impact of proton pump inhibitor use on fusion rates following single-level lumbar spinal fusion surgery. Eur Spine J 34(9):4083\u20134087","DOI":"10.1007\/s00586-025-08977-9"},{"issue":"4","key":"9767_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.joca.2021.12.010","volume":"30","author":"C Zeng","year":"2022","unstructured":"Zeng C et al (2022) Proton pump inhibitor therapy and risk of knee replacement surgery: a general population-based cohort study. Osteoarthr Cartil 30(4):559\u2013569","journal-title":"Osteoarthr Cartil"},{"issue":"9","key":"9767_CR12","first-page":"560","volume":"9","author":"EM Quigley","year":"2013","unstructured":"Quigley EM (2013) Gut bacteria in health and disease. Gastroenterol Hepatol (N Y) 9(9):560\u2013569","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"6 Suppl","key":"9767_CR13","doi-asserted-by":"publisher","first-page":"S356","DOI":"10.1097\/00003246-200206001-00003","volume":"30","author":"JR Pisegna","year":"2002","unstructured":"Pisegna JR (2002) Pharmacology of acid suppression in the hospital setting: focus on proton pump Inhibition. Crit Care Med 30(6 Suppl):S356\u2013S361","journal-title":"Crit Care Med"},{"issue":"7","key":"9767_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1060028018760569","volume":"52","author":"RA Hafiz","year":"2018","unstructured":"Hafiz RA et al (2018) The risk of community-acquired enteric infection in proton pump inhibitor therapy: systematic review and meta-analysis. Ann Pharmacother 52(7):613\u2013622","journal-title":"Ann Pharmacother"},{"key":"9767_CR15","doi-asserted-by":"crossref","unstructured":"Zeng R et al (2024) Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: evidence from a large population-based cohort study. Elife 13:RP94973","DOI":"10.7554\/eLife.94973.3"},{"issue":"8","key":"9767_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00535-023-02007-5","volume":"58","author":"J Maret-Ouda","year":"2023","unstructured":"Maret-Ouda J et al (2023) Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study. J Gastroenterol 58(8):734\u2013740","journal-title":"J Gastroenterol"},{"issue":"4","key":"9767_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX (2017) The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 152(4):706\u2013715","journal-title":"Gastroenterology"},{"issue":"4","key":"9767_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.gastro.2016.11.023","volume":"152","author":"JR Lam","year":"2017","unstructured":"Lam JR et al (2017) Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology 152(4):821\u2013829e1","journal-title":"Gastroenterology"},{"issue":"2","key":"9767_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/joim.12826","volume":"285","author":"A Tran-Duy","year":"2019","unstructured":"Tran-Duy A et al (2019) Use of proton pump inhibitors and risk of iron deficiency: a population\u2010based case\u2013control study. J Intern Med 285(2):205\u2013214","journal-title":"J Intern Med"},{"issue":"22","key":"9767_CR20","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR et al (2013) Proton pump inhibitor and Histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 310(22):2435\u20132442","journal-title":"JAMA"},{"key":"9767_CR21","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s10620-011-1589-y","volume":"56","author":"E Sarzynski","year":"2011","unstructured":"Sarzynski E et al (2011) Association between proton pump inhibitor use and anemia: a retrospective cohort study. Dig Dis Sci 56:2349\u20132353","journal-title":"Dig Dis Sci"},{"issue":"1","key":"9767_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1359\/JBMR.041018","volume":"20","author":"KL Tucker","year":"2005","unstructured":"Tucker KL et al (2005) Low plasma vitamin B12 is associated with lower BMD: the Framingham osteoporosis study. J Bone Miner Res 20(1):152\u2013158","journal-title":"J Bone Miner Res"},{"issue":"10","key":"9767_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1056\/NEJMcibr1407247","volume":"371","author":"TL Clemens","year":"2014","unstructured":"Clemens TL (2014) Vitamin B12 deficiency and bone health. N Engl J Med 371(10):963\u2013964","journal-title":"N Engl J Med"},{"issue":"2","key":"9767_CR24","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2020.5.FOCUS20289","volume":"49","author":"SI Khalid","year":"2020","unstructured":"Khalid SI et al (2020) Association of osteopenia and osteoporosis with higher rates of pseudarthrosis and revision surgery in adult patients undergoing single-level lumbar fusion. NeuroSurg Focus 49(2):E6","journal-title":"NeuroSurg Focus"},{"issue":"2","key":"9767_CR25","doi-asserted-by":"publisher","first-page":"e54727","DOI":"10.7759\/cureus.54727","volume":"16","author":"KN Bekas","year":"2024","unstructured":"Bekas KN, Zafeiris C (2024) The role of bone mineral density in a successful lumbar interbody fusion: a narrative review. Cureus 16(2):e54727. https:\/\/doi.org\/10.7759\/cureus.54727","journal-title":"Cureus"},{"issue":"1","key":"9767_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/2192568219853222","volume":"10","author":"JJ Mangan","year":"2020","unstructured":"Mangan JJ 3 et al (2020) Proton pump inhibitor use affects pseudarthrosis rates and influences Patient-Reported outcomes. Global Spine J 10(1):55\u201362","journal-title":"Global Spine J"},{"key":"9767_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00223-018-0432-2","volume":"103","author":"JM Paik","year":"2018","unstructured":"Paik JM et al (2018) Proton pump inhibitor use, H 2-receptor antagonist use, and risk of incident clinical vertebral fracture in women. Calcif Tissue Int 103:380\u2013387","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"9767_CR28","doi-asserted-by":"publisher","first-page":"e13846","DOI":"10.1111\/apha.13846","volume":"235","author":"LMM Gommers","year":"2022","unstructured":"Gommers LMM, Hoenderop JGJ, de Baaij JHF (2022) Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiol (Oxf) 235(4):e13846","journal-title":"Acta Physiol (Oxf)"},{"issue":"5","key":"9767_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","volume":"66","author":"BC Kieboom","year":"2015","unstructured":"Kieboom BC et al (2015) Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis 66(5):775\u2013782","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"9767_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM198507113130202","volume":"313","author":"RR Recker","year":"1985","unstructured":"Recker RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313(2):70\u201373","journal-title":"N Engl J Med"},{"issue":"7","key":"9767_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","volume":"118","author":"MB O\u2019Connell","year":"2005","unstructured":"O\u2019Connell MB et al (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118(7):778\u2013781","journal-title":"Am J Med"},{"issue":"10","key":"9767_CR32","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/jgs.13661","volume":"63","author":"AM Hinson","year":"2015","unstructured":"Hinson AM et al (2015) Hyperparathyroidism associated with long-term proton pump inhibitors independent of concurrent bisphosphonate therapy in elderly adults. J Am Geriatr Soc 63(10):2070\u20132073","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"9767_CR33","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00198-023-06867-8","volume":"34","author":"D Fitzpatrick","year":"2023","unstructured":"Fitzpatrick D et al (2023) The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture\u2014results of a large observational cohort study. Osteoporos Int 34(11):1917\u20131926","journal-title":"Osteoporos Int"},{"issue":"2","key":"9767_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.arcmed.2010.02.006","volume":"41","author":"MR Namazi","year":"2010","unstructured":"Namazi MR, Jowkar F (2010) Can proton pump inhibitors accentuate skin aging? Arch Med Res 41(2):147\u2013148","journal-title":"Arch Med Res"},{"issue":"1","key":"9767_CR35","doi-asserted-by":"publisher","first-page":"14081","DOI":"10.1038\/s41598-020-70712-9","volume":"10","author":"Y-S Chou","year":"2020","unstructured":"Chou Y-S et al (2020) Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes. Sci Rep 10(1):14081","journal-title":"Sci Rep"},{"issue":"4","key":"9767_CR36","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/nu7042324","volume":"7","author":"L Toxqui","year":"2015","unstructured":"Toxqui L, Vaquero MP (2015) Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis. Nutrients 7(4):2324\u20132344","journal-title":"Nutrients"},{"issue":"3","key":"9767_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11914-013-0155-2","volume":"11","author":"KMA Swart","year":"2013","unstructured":"Swart KMA, van Schoor NM, Lips P (2013) Vitamin B12, folic Acid, and bone. Curr Osteoporos Rep 11(3):213\u2013218","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"9767_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.12698","volume":"283","author":"TS Sehested","year":"2018","unstructured":"Sehested TS et al (2018) Long-term use of proton pump inhibitors, dose\u2013response relationship and associated risk of ischemic stroke and myocardial infarction. J Intern Med 283(3):268\u2013281","journal-title":"J Intern Med"},{"key":"9767_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2018.08.035","volume":"277","author":"M Casula","year":"2018","unstructured":"Casula M et al (2018) Use of proton pump inhibitors and risk of ischemic events in the general population. Atherosclerosis 277:123\u2013129","journal-title":"Atherosclerosis"},{"key":"9767_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejim.2019.11.017","volume":"72","author":"AA Manolis","year":"2020","unstructured":"Manolis AA et al (2020) Proton pump inhibitors and cardiovascular adverse effects: real or surreal worries? Eur J Intern Med 72:15\u201326","journal-title":"Eur J Intern Med"},{"issue":"10","key":"9767_CR41","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1681\/ASN.2015121377","volume":"27","author":"Y Xie","year":"2016","unstructured":"Xie Y et al (2016) Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 27(10):3153\u20133163","journal-title":"J Am Soc Nephrol"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-026-09767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-026-09767-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-026-09767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:04:25Z","timestamp":1791000265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-026-09767-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9767"],"URL":"https:\/\/doi.org\/10.1007\/s00586-026-09767-7","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}